Management of multidrug-resistant tuberculosis: main recommendations of the Brazilian guidelines

Departamento de Enfermagem Materno-Infantil e Saúde PúblicaBallestero, Jaqueline Garcia de Almeida; Garcia, Juliana Masini; Departamento de Clínica MédicaBollela, Valdes Roberto; Departamento de Medicina SocialRuffino-Netto, Antonio; Centro de Referência Professor Hélio FragaDalcolmo, Margareth Maria Pretti; Departamento de EnfermagemMoncaio, Ana Carolina Scarpel; Miguel, Nicoly Sanches; Rigolin, Isabela Zaccaro; Departamento de Enfermagem Materno-Infantil e Saúde PúblicaPalha, Pedro Fredemir.
J. bras. pneumol ; 46(2): e20190290, 2020. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1134862

Documentos relacionados

  1. Management of multidrug-resistant tuberculosis: main recommendations of the Brazilian guidelines.
  2. Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
  3. [Annual progress of immunotherapy for tuberculosis in 2023].
  4. Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda.
  5. Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova.
  6. Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism.
  7. [Comprehensive clinical evaluation of bedaquiline in the treatment of multidrug-resistant tuberculosis].
  8. Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting.
  9. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies.
  10. Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs.